For all of these Mφ phenotypes, a trend for localization in stromal (ST) rather than in intratumoral (INT) regions of UCB tissues, as well as a higher frequency of ST-infiltrating CD204+ Mφs, could predict a poor prognosis, independent of other tumor-infiltrating Mφ phenotypic markers and clinical variables. This evidence concerns the gene MSR1 and neoplasm.